Healthcare

https://techpapersworld.com/wp-content/uploads/2024/05/Study-at-Japans-Kameda-Medical-1-1280x720.jpg

HealthcareOwkin Announces MSIntuit® CRC v2, a Next-Generation AI Diagnostic Aimed at Transforming the Detection and Treatment of Colorectal Cancer

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development, and diagnostics has announced MSIntuit® CRC v21, a next-generation AI solution. Aimed at transforming the detection and treatment of colorectal cancer (CRC), MSIntuit® CRC v2 will initially launch as an RUO version in the US on Roche’s navify® Digital Pathology enterprise software. MSIntuit® CRC v2 builds upon the success of the CE-IVD-certified MSIntuit® CRC, integrating cutting-edge machine learning models developed by Owkin with...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/02/ScreenPoint-Medical-1280x720.jpg

HealthcareOttimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 2025

Ottimo Pharma, a private biotech company, announces the appointment of world class industry veterans David Epstein as Chair & Chief Executive Officer, Mehdi Shahidi as Head of Development & Chief Medical Officer and James Sabry as Vice-Chair of the Board of Directors. Ottimo Pharma, co-founded by Medicxi and Jonny Finlay in 2020, is developing Jankistomig, a PD1-VEGFR2 bi-functional antibody, designed as a dual-pathway, single agent, IgG therapy targeting immune checkpoint inhibition and angiogenesis in the treatment of cancer. David Epstein, Chair & Chief...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2023/07/Red-e-App-announces-a-new-1280x720.jpg

HealthcareCorvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients

Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced impressive three-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and sustained efficacy of the Corvia® Atrial Shunt in selected heart failure patients with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction. The results were published in The American Heart Journal. REDUCE LAP-HF II is the world’s first phase III trial to evaluate safety and efficacy of an atrial...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/07/Neusoft-Remains-No.1-in-China-1280x720.jpg

HealthcarePrime Staffing Defies Industry Trends: Expanding and Hiring Amidst Widespread Healthcare Staffing Layoffs

While the healthcare staffing industry is facing widespread layoffs and downsizing, Prime Staffing, a trusted mainstay in the national healthcare staffing market, is bucking the trend. With an eye toward growth and innovation, Prime Staffing is proud to announce its ongoing expansion, hiring initiatives, and the opening of new offices in India and the Philippines to supplement its U.S.team. In contrast to many firms that are struggling with a slowdown in demand and organizational cutbacks, Prime Staffing is experiencing sustained...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2023/11/Meet-Joey-Rabbit-the-New-1280x720.jpg

HealthcareTASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability

On October 24, 2024, TASTE-2, a Chinese innovative stroke drug study led by Professor Wang Yongjun from Beijing Tiantan Hospital, was published in an oral report at the 16th World Stroke Conference (WSC): brain cell protection combined with edaravone dexborneol (Sanbexin ®) in patients with acute ischemic stroke before endovascular thrombectomy significantly improved the proportion of patients who recovered neurological independence at 90 days and reduced the proportion of patients with disability. Professor Wang Yongjun from Beijing...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/03/One-Million-Global-Healthcare-1280x720.jpg

HealthcareCaristo Diagnostics Wins Digital Health Award for CaRi-Heart® Cardiac Risk Prediction Technology

Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, has been selected a winner of the Digital Health Hub Foundation: Digital Health Awards. Caristo was named a “Rising Star” in the Provider Diagnostics Category of the prestigious awards, presented Oct. 21 at the global HLTH 2024 conference in Las Vegas. Caristo’s CaRi-Heart® cardiac risk prediction technology was the first innovation highlighted in the conference’s opening ceremony by Jonathan Weiner, Founder, Chairman & CEO of HLTH. Caristo’s CaRi-Heart Technology showcased at HLTH...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/08/Invenio-Imaging-Announces-First-1280x720.jpg

HealthcareAIRS Medical and HealthCare Konnect Partner to Revolutionize MRI Efficiency in Switzerland With SwiftMR®

AIRS Medical, a global leader in AI-powered diagnostic imaging solutions, has partnered with HealthCare Konnect, a prominent Swiss healthcare distribution platform. This collaboration will accelerate access to SwiftMR, the award-winning1 MRI acceleration software from AIRS Medical, throughout Switzerland. Enhancing MRI efficiency and patient care SwiftMR harnesses advanced deep learning technology to reduce MRI scan times by up to 50%2 while generating sharper images. By enabling radiology centers to scan more patients within the same time frame, SwiftMR not only boosts operational...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/07/XRP-Healthcare-Halts-New-1280x720.jpg

HealthcareHELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure

HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for “Allogeneic Human iPSC-derived cardiomyocytes (HiCM-188) administered via intramyocardial injection during coronary artery bypass graft surgery.” Heart failure (HF) is a significant public health issue, affecting at least 7 million patients in the US and approximately 65 million globally. Due to its increasing incidence and prevalence among the elderly, heart...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/05/Study-at-Japans-Kameda-Medical-1280x720.jpg

HealthcareEngineering Creates Molecules That Target Cancer-Causing Proteins

For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and causing cancer. But despite causing major disease, these slightly mutated proteins can resemble their normal versions so closely that treatments designed to target mutants could also harm healthy cells. Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, a new study describes the development of a biologic, a...

by PRNewswire

https://techpapersworld.com/wp-content/uploads/2024/09/QingSong-Health-Chairman-Speaks-at-Global-1280x720.jpg

HealthcareUniversity hospitals in the UK join Homerton Healthcare’s public cloud service from Sectra–enhances collaboration for improved care

International medical imaging IT and cybersecurity company Sectra’s (STO: SECT B) SaaS in the cloud, Sectra One Cloud, will be used by Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) in the UK as they join Homerton Healthcare’s current cloud solution for medical imaging. By using one unified platform the current cooperation between the hospitals will be enhanced which is anticipated to improve workflow and production at lower cost. Moreover, it will relieve BHRUT’s IT burden and...

Newer Posts

Older Posts